Authors' reply

BJOG: An International Journal of Obstetrics & GynaecologyVolume 130, Issue 7 p. 839-839 LETTER TO THE EDITOR Authors' reply K. H. Nicolaides, Corresponding Author K. H. Nicolaides [email protected] Fetal Medicine Research Institute, King's College Hospital, London, UK Correspondence K. H. Nicolaides, Harris Birthright Research Centre for Fetal Medicine, Fetal Medicine Research Institute, King's College Hospital, Denmark Hill, London SE5 8BB, UK. Email: [email protected]Search for more papers by this authorD. Wright, D. Wright Institute of Health Research, University of Exeter, Exeter, UKSearch for more papers by this author K. H. Nicolaides, Corresponding Author K. H. Nicolaides [email protected] Fetal Medicine Research Institute, King's College Hospital, London, UK Correspondence K. H. Nicolaides, Harris Birthright Research Centre for Fetal Medicine, Fetal Medicine Research Institute, King's College Hospital, Denmark Hill, London SE5 8BB, UK. Email: [email protected]Search for more papers by this authorD. Wright, D. Wright Institute of Health Research, University of Exeter, Exeter, UKSearch for more papers by this author First published: 12 April 2023 https://doi.org/10.1111/1471-0528.17482Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Leeson C, Odendaal J, Quenby S. Re: Serum PlGF compared to PAPP-A in first trimester screening for preterm pre-eclampsia: adjusting for the effect of aspirin treatment. BJOG. 2022. https://doi.org/10.1111/1471-0528.17182 2Wright D, Tan MY, O'Gorman N, Syngelaki A, Nicolaides KH. Serum PlGF compared to PAPP-A in first trimester screening for preterm pre-eclampsia: adjusting for the effect of aspirin treatment. BJOG. 2022; 129: 1308–17. https://doi.org/10.1111/1471-0528.17096 3Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, et al. The hypertensive disorders of pregnancy: the 2021 International Society for the Study of hypertension in pregnancy classification, diagnosis and management recommendations for international practice. Pregnancy Hypertens. 2022; 27: 148–69. 4Lai J, Syngelaki A, Nicolaides KH, von Dadelszen P, Magee LA. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes. Am J Obstet Gynecol. 2021; 224: 518.e1–518.e11. 5Papastefanou I, Wright D, Lolos M, Anampousi K, Mamalis M, Nicolaides KH. Competing-risks model for prediction of small-for-gestational-age neonate from maternal characteristics, serum pregnancy-associated plasma protein-a and placental growth factor at 11-13 weeks' gestation. Ultrasound Obstet Gynecol. 2021; 57: 392–400. Volume130, Issue7June 2023Pages 839-839 ReferencesRelatedInformation